Are Dividend Giants BHP Billiton plc, GlaxoSmithKline plc And HSBC Holdings plc Worth A Buy?

Are Dividend Giants BHP Billiton plc (LON:BLT), GlaxoSmithKline plc (LON:GSK) And HSBC Holdings plc (LON:HSBA) Worth A Buy?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

These dividend giants all pay out huge yields that are great for any portfolio. As you can see in the table below all three companies pay more than 6% dividend yield against a FTSE 100 average yield of 4%. Income stocks are becoming a popular addition to many portfolios and should be part of every investor’s research. The three companies listed below are some of the UK’s most popular stocks. 

  Dividend
Yield
Dividend
Cover
BHP 11.7% 0.4
GlaxoSmithKline 6.17% 0.83
HSBC 6.3% 1.58

BHP Billiton

BHP Billiton (LSE: BLT), like many other commodity-based companies, has had a year to forget. Commodity prices are falling ever lower and the company has recently had an environmental disaster in Brazil where 13 people died in a dam burst. The company pays a huge dividend that is coming under threat due to declining revenues and a possible $3.5bn fine for the dam burst in Brazil. 

The dividend cover of 0.4 is less than reassuring, too, and commodity prices don’t look like shooting higher any time soon. Investors that buy the shares now and hold for the long term may well be rewarded well, but should expect short term pain first. 

GlaxoSmithKline

GlaxoSmithKline’s (LSE: GSK) share price has also been under increased pressure, due to blockbuster drugs coming off patent. This has come as a slight surprise to many, as Glaxo has an exiting pipeline of new drugs that should boost company earnings and fill the earnings gap. City analysts forecast strong earnings growth in 2016 and 2017, which should also give strength to its dividend.

At a current yield of 6.1% it looks a solid bet for the next few years, with big growth prospects for such a large company. 

HSBC

HSBC (LSE: HSBA) currently has a P/E ratio of just over 9.5, which implies the company is undervalued and has scope for growth. This growth should be provided by HSBC’s emerging market business and 2016 looks like it may be a good year in these emerging countries. China and India have both had good growth numbers come out in the last few weeks which is encouraging. The company has also identified billions worth of savings that should do wonders for the bank going forward. 

The three companies listed here all offer various risk profiles that should always be taken into account before investing. BHP is the ‘higher risk’ company, due to the declining commodities environment, and its dividend may well have to be cut to conserve cash. It does however offer the highest yield in the FSTE 100,  so for brave investors that believe in the company this could well be the buying opportunity of the decade. GlaxoSmithKline and HSBC are ‘lower risk’ plays, offering solid income with growth prospects too. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jack Dingwall has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline and HSBC Holdings. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Black man sat in front of laptop while wearing headphones
Investing Articles

3 of the best FTSE 100 stocks to consider in May

FTSE stocks are back in fashion as investors look for undervalued shares. Here are some our writer Royston Wild thinks…

Read more »

Mixed-race female couple enjoying themselves on a walk
Investing Articles

£7,000 in savings? Here’s what I’d do to turn that into a £1,160 monthly passive income

With some careful consideration, it's possible to make an excellent passive income for life with UK shares. This is how…

Read more »

Investing Articles

If I’d invested £1k in Amazon stock when it went public, here’s what I’d have today

Amazon stock has been one of the biggest winners over the last couple of decades. Muhammad Cheema takes a look…

Read more »

Investing Articles

If I’d put £5,000 in Nvidia stock 5 years ago, here’s what I’d have now

Nvidia stock has been a great success story in the past few years. This Fool breaks down how much he'd…

Read more »

Young black woman walking in Central London for shopping
Investing Articles

Could investing in a Shein IPO make my ISA shine?

With chatter that London might yet see a Shein IPO, our writer shares his view on some possible pros and…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

The FTSE 100 reached record highs in April! Here’s what investors should consider buying in May

The FTSE 100 continues to impress in 2024 as last month it reached new highs. Here are two stocks investors…

Read more »

Investing Articles

Despite hitting a 52-week high, Coca-Cola HBC stock still looks great value

Our writer reckons one flying UK share that has been participating in the recent FTSE 100 bull run remains a…

Read more »

Investing Articles

Is this the best stock to invest in right now?

Roland Head explains why he likes this FTSE 250 business so much and wonders if it could be the best…

Read more »